Current position:Home >Product >
L-Glutamic acid, N-[N-(trimethylsilyl)-L-a-aspartyl]-, tris(trimethylsilyl) ester
L-Glutamic acid, N-[N-(trimethylsilyl)-L-a-aspartyl]-, tris(trimethylsilyl) ester(67558-71-8)
- Name: L-Glutamic acid, N-[N-(trimethylsilyl)-L-a-aspartyl]-, tris(trimethylsilyl) ester
- Synonyms:
- Molecular Formula:C21H46N2O7Si4
- Molecular Weight:
- CAS Registry Number:67558-71-8
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 675586-90-0/L-Serine, O-[[3-[2-(2-benzoxazolylmethylamino)ethyl]-5-isoxazolyl]methyl]-N-(meth ylsulfonyl)-
- 675586-92-2/L-Serine, O-[[3-[(1E)-2-(2-benzoxazolylmethylamino)ethenyl]-5-isoxazolyl]methyl]- N-(phenylmethyl)-
- 675586-94-4/L-Serine, O-[[3-[1-hydroxy-6-(methyl-2-pyridinylamino)hexyl]-5-isoxazolyl]methyl]- N-(phenylmethyl)-
- 675586-95-5/L-Serine, O-[[3-[2-hydroxy-6-(methyl-2-pyridinylamino)hexyl]-5-isoxazolyl]methyl]- N-(phenylmethyl)-
- 675586-96-6/L-Serine, O-[[3-[6-(2-benzoxazolylmethylamino)-4-hydroxyhexyl]-5-isoxazolyl]meth yl]-N-(methylsulfonyl)-
- 675586-97-7/L-Serine, O-[[3-[4-hydroxy-6-(methyl-2-pyridinylamino)hexyl]-5-isoxazolyl]methyl]- N-(phenylsulfonyl)-
- 675586-98-8/L-Serine, O-[[3-[4-hydroxy-6-(methyl-2-pyridinylamino)hexyl]-5-isoxazolyl]methyl]- N-(phenylmethyl)-
- 675586-99-9/L-Serine, O-[[3-[4-hydroxy-5-(methyl-2-pyridinylamino)pentyl]-5-isoxazolyl]methyl]- N-(methylsulfonyl)-
- 675587-00-5/L-Serine, O-[[3-[4-(2-benzoxazolylmethylamino)-2-hydroxybutyl]-5-isoxazolyl]meth yl]-N-(methylsulfonyl)-
- 675587-01-6/L-Serine, O-[[3-[3-hydroxy-4-(methyl-2-pyridinylamino)butyl]-5-isoxazolyl]methyl]-N -(phenylmethyl)-
- 675587-02-7/L-Serine, O-[[3-[1-hydroxy-3-(methyl-2-pyridinylamino)propyl]-5-isoxazolyl]methyl]- N-(phenylmethyl)-
- 675587-03-8/L-Serine, O-[[3-[3-hydroxy-3-(methyl-2-pyridinylamino)propyl]-5-isoxazolyl]methyl]- N-(methylsulfonyl)-
- 675587-04-9/L-Serine, O-[[3-[1-hydroxy-2-(methyl-2-pyridinylamino)ethyl]-5-isoxazolyl]methyl]-N -(methylsulfonyl)-
- 675587-05-0/L-Cysteine, N-[4-[4-(formylamino)phenyl]butyl]-S-[[3-[6-(3-phenyl-5-isoxazolyl)hexyl]- 5-isoxazolyl]methyl]-
- 675587-07-2/L-Cysteine, S-[[3-[6-(5-methyl-2-phenyl-4-oxazolyl)hexyl]-5-isoxazolyl]methyl]-N-[4-(2 -nitrophenyl)butyl]-
- 675587-08-3/L-Cysteine, N-[3-[2-(formylamino)phenyl]propyl]-S-[[3-[6-(3-phenyl-5-isoxazolyl)hexyl ]-5-isoxazolyl]methyl]-
- 675587-10-7/L-Cysteine, N-[2-(4-ethoxyphenyl)ethyl]-S-[[3-[6-(5-methyl-2-phenyl-4-oxazolyl)hexyl]- 5-isoxazolyl]methyl]-
- 675587-14-1/L-Cysteine, N-[[(1,1-dioxidobenzo[b]thien-2-yl)methoxy]carbonyl]-S-[[3-[6-(1-naphth alenyl)hexyl]-5-isoxazolyl]methyl]-
- 675587-15-2/L-Cysteine, N-[[(1,1-dioxidobenzo[b]thien-2-yl)methoxy]carbonyl]-S-[[3-[6-(2-naphth alenyl)hexyl]-5-isoxazolyl]methyl]-
- 67558-71-8/L-Glutamic acid, N-[N-(trimethylsilyl)-L-a-aspartyl]-, tris(trimethylsilyl) ester
- 675587-18-5/L-Cysteine, N-[4-[3-(hydroxymethyl)phenyl]butyl]-S-[[3-[5-(9H-pyrido[3,4-b]indol-9-yl) pentyl]-5-isoxazolyl]methyl]-
- 675587-21-0/L-Cysteine, N-[4-[2-(hydroxymethyl)phenyl]butyl]-S-[[3-[5-(9H-pyrido[3,4-b]indol-9-yl) pentyl]-5-isoxazolyl]methyl]-
- 675587-23-2/L-Cysteine, N-[3-[2-(formylamino)phenyl]propyl]-S-[[3-[5-(9H-pyrido[3,4-b]indol-9-yl) pentyl]-5-isoxazolyl]methyl]-
- 675587-26-5/L-Cysteine, N-[2-(3-ethoxyphenyl)ethyl]-S-[[3-[5-(5-methyl-2-phenyl-4-oxazolyl)pentyl ]-5-isoxazolyl]methyl]-
- 675587-27-6/L-Cysteine, N-[[(1,1-dioxidobenzo[b]thien-2-yl)methoxy]carbonyl]-S-[[3-[5-(methyl-2- pyridinylamino)pentyl]-5-isoxazolyl]methyl]-
- 67558-72-9/L-Isoleucine, N-[N-(trimethylsilyl)-L-a-aspartyl]-, bis(trimethylsilyl) ester
- 675587-29-8/L-Cysteine, N-[[(1,1-dioxidobenzo[b]thien-2-yl)methoxy]carbonyl]-S-[[3-[5-(2-naphth alenyl)pentyl]-5-isoxazolyl]methyl]-
- 675587-54-9/L-Serine, N-[(4-ethoxyphenyl)methyl]-O-[[3-[3-(1-naphthalenyl)propyl]-5-isoxazolyl] methyl]-
- 675587-52-7/L-Serine, N-[2-(4-aminophenyl)ethyl]-O-[[3-[3-(9H-pyrido[3,4-b]indol-9-yl)propyl]-5 -isoxazolyl]methyl]-
- 67558-75-2/L-Phenylalanine, N-[N-(trimethylsilyl)-L-a-aspartyl]-, bis(trimethylsilyl) ester